Clinical Trials Sponsored by CKD Bio Corporation

Total 29 results

CKD Bio Corporation

Completed

Safety and Efficacy of CKDB-501A in Subjects With Post-stroke Upper Limb Spasticity

Post-stroke Upper Limb Spasticity

Korea, Republic of
CKD Bio Corporation

Completed

Safety and Efficacy of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines

Glabellar Lines

Korea, Republic of
CKD Bio Corporation

Completed

Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial

Glabellar Lines

Korea, Republic of
CKD Bio Corporation

Completed

Safety and Efficacy of CKDB-501B in Subjects With Moderate-to-severe Glabellar Lines

Glabellar Lines

Korea, Republic of
Haffkine Bio-Pharmaceutical Corporation Ltd.

Completed

AScVS and/ or Prazosin for Scorpion Envenomation

Scorpion Envenomation

India
Tetra Bio-Pharma
Cognitive Research Corporation

Recruiting

Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain (REBORN)

Cancer | Breakthrough Cancer Pain

United States
Belx Bio-Pharmaceutical (Taiwan) Corporation
A2 Healthcare Taiwan Corporation

Terminated

Evaluate the Safety of BEL-X-HG in Advanced Cancer Patients

Advanced Solid Tumors

Taiwan
ESM Technologies, LLC
QPS Bio-Kinetic; KD Pharma Group

Completed

NEM® + KD PUR® Fish Oil Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women (Move3)

Exercise-induced Joint Pain | Exercise-induced Joint Stiffness | Exercise-induced Joint Cartilage Turnover

United States
Taiwan Bio Therapeutics Co., Ltd.
A2 Healthcare Taiwan Corporation

Active, not recruiting

Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)

Osteoarthritis, Knee

Taiwan
Hamad Medical Corporation
Hamad Bin Khalifa University

Unknown

Impact of Body Composition and Exercise on Clinical, Metabolic and Molecular Parameters in Type 2 Diabetics in Qatar

Type 2 Diabetes

Qatar
AIO-Studien-gGmbH
Celgene Corporation; ClinAssess GmbH

Completed

Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer (NEOLAP)

Ductal Adenocarcinoma of the Pancreas

Germany
AIO-Studien-gGmbH
Celgene Corporation; ClinAssess GmbH

Completed

First-line Treatment of Metastatic Pancreatic Cancer With Nab-paclitaxel and Gemcitabine (ALPACA)

Adenocarcinoma of the Pancreas | Metastatic Pancreatic Cancer

Germany
Alliancells-PuRui Biocience Co., Ltd.
Zhongyuan Union Stem Cell Bio-engineering Corporation

Unknown

Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection

Renal Cell Carcinoma | Hepatocellular Carcinoma | Lung Cancer

China
Treos Bio Zrt
Mayo Clinic; University of Pisa; PPD; Laboratory Corporation of America; ImmunXperts...

Completed

PolyPEPI1018 Vaccine and CDx for the Treatment of Metastatic Colorectal Cancer (OBERTO) (OBERTO)

Colorectal Cancer

United States, Italy
Eisai Inc.
PPD; MDS Pharma Services; Bio Analytical Research Corporation; Coghlan Group (Plasma...

Completed

A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy

Colonoscopy | Colon Polyps
CFD Research Corporation
University of Kansas Medical Center; National Institute on Deafness and Other...

Recruiting

Individualized Vestibular Rehabilitation for Elderly With Self-Management and Gaming Elements

Vestibular Diseases | Balance; Distorted | Vestibular Disorder

United States
Veronika Bachanova
Bristol-Myers Squibb; Incyte Corporation

Recruiting

Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

Hodgkin Lymphoma

United States
Al B. Benson, III, MD
Celgene Corporation; Big Ten Cancer Research Consortium

Completed

FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma

Gastric Cancer | Gastro-Esophageal Junction Adenocarcinoma

United States
Seoul National University Hospital
Boston Scientific Korea Co. Ltd; Dio; Terumo Corporation; Abbott

Unknown

Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)

Acute Coronary Syndrome

Korea, Republic of
Renmin Hospital of Wuhan University
Beijing SH Bio-Tech Corporation, Beijing (CN); Utooth Biological Technology...

Recruiting

Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients

COVID-19

China
Eisai Inc.
Omnicare Clinical Research; MDS Pharma Services; Bio Analytical Research Corporation and other collaborators

Completed

A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy

Colonoscopy | Colon Polyps
Imam Abdulrahman Bin Faisal University
The Saline Water Conversion Corporation Research Institute at Al-Jubail,...

Completed

Is Mg do Improve the Glycemic Control in Patients Drink a Desalinate Water (Mg)

Diabetes Mellitus | Glucose, High Blood | Patients

Saudi Arabia
Conmed Pharmaceutical & Bio-Medical Corporation
Chang Gung Memorial Hospital; Kaohsiung Medical University; Tri-Service General... and other collaborators

Completed

AST-120 in Hemodialysis Patients With Uremic Pruritus (AST-120)

Uremic Pruritus

Taiwan
AIO-Studien-gGmbH
Bristol-Myers Squibb; Eli Lilly and Company; Merck Sharp & Dohme LLC; Pfizer; Gilead... and other collaborators

Recruiting

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients (CRISP)

Small-cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage I | Metastatic Non-small Cell Lung Cancer (NSCLC) | Non Small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer Stage II

Germany
Qatar University
Cairo University; NYU Langone Health; Mahidol University; Jordan University of... and other collaborators

Recruiting

Pulpotomy in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis

Irreversible Pulpitis

Qatar
Wits Health Consortium (Pty) Ltd
Fred Hutchinson Cancer Center; Janssen Vaccines & Prevention B.V.; National Institute... and other collaborators

Completed

Sisonke (Together): OPEN LABEL TRIAL COVID-19 (Sisonke)

SARS (Severe Acute Respiratory Syndrome)

South Africa
Wits Health Consortium (Pty) Ltd
Fred Hutchinson Cancer Center; Janssen Vaccines & Prevention B.V.; Right to Care and other collaborators

Recruiting

Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study. (Sisonke Boost)

SARS CoV 2 Infection

South Africa
Paul Richardson, MD
M.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts... and other collaborators

Active, not recruiting

Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 (DFCI 10-106)

Multiple Myeloma

United States
Fatebenefratelli Hospital
Federico II University; Federal University of Rio Grande do Sul; Royal Brompton... and other collaborators

Recruiting

Stress Echo 2020 - The International Stress Echo Study (SE2020)

Coronary Artery Disease | Heart Failure | Aortic Valve Disease | Pulmonary Arterial Hypertension | Tetralogy of Fallot | Hypertrophic Cardiomyopathy | Athletes Heart

Italy

Clinical Trials Sponsored by CKD Bio Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations